Treatment and outcomes of metastatic colorectal cancer in Australia: defining differences between public and private practice (vol 45, pg 267, 2015)

被引：0
|
作者：
Field, K.
Shapiro, J.
Wong, H. -L.
Tacey, M.
Nott, L.
Tran, B.
Turner, N.
Ananda, S.
Richardson, G.
Jennens, R.
Wong, R.
Power, J.
Burge, M.
Gibbs, P.
机构：
来源：
INTERNAL MEDICINE JOURNAL | 2015年 / 45卷 / 06期
关键词：
D O I：
10.1111/imj.12801_2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：690 / 690
页数：1
相关论文
共 50 条
  • [31] Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC) (vol 11, pg 489, 2016)
    Scartozzi, Mario
    Vincent, Loic
    Chiron, Marielle
    Cascinu, Stefano
    [J]. TARGETED ONCOLOGY, 2017, 12 (01) : 123 - 123
  • [32] RETRACTION: Efficient inhibition of growth of metastatic cancer cells after resection of primary colorectal cancer by soluble Flt-1 (Retraction of Vol 36, Pg 7399, 2015)
    Zhang, Y.
    Li, A.
    Peng, W.
    [J]. TUMOR BIOLOGY, 2017,
  • [33] Fertility in Women of Reproductive Age After Breast Cancer Treatment: Practice Patterns and Outcomes (vol 23, pg 3175, 2016)
    McCray, Devina K. S.
    Simpson, Ashley B.
    Flyckt, Rebecca
    Liu, Yitian
    O'Rourke, Colin
    Crowe, Joseph P.
    Grobmyer, Stephen R.
    Moore, Halle C.
    Valente, Stephanie A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S1063 - S1063
  • [34] Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival? (vol 108, pg 292, 2013)
    Forbes, L. J. L.
    Simon, A. E.
    Warburton, F.
    Boniface, D.
    Brain, K. E.
    Dessaix, A.
    Donnelly, C.
    Haynes, K.
    Hvidberg, L.
    Lagerlund, M.
    Lockwood, G.
    Tishelman, C.
    Vedsted, P.
    Vigmostad, M. N.
    Ramirez, A. J.
    Wardle, J.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 111 (12) : 2382 - 2382
  • [35] Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer (vol 355, pg 1041, 2000)
    Douillard, JY
    [J]. LANCET, 2000, 355 (9212): : 1372 - 1372
  • [36] Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis (vol 94, pg 191, 2018)
    Petrelli, Fausto
    Ardito, Raffaele
    Ghidini, Antonio
    Zaniboni, Alberto
    Ghidini, Michele
    Barni, Sandro
    Tomasello, Gianluca
    [J]. ONCOLOGY, 2024, 102 (06) : 547 - 547
  • [37] Cancer of the Prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 26, pg v69, 2015)
    Parker, C.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : v148 - v148
  • [38] Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 26, pg v56, 2015)
    Ducreux, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 167 - 168
  • [39] Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients (vol 11, pg 965, 2015)
    Caffo, Orazio
    Lo Re, Giovanni
    Sava, Teodoro
    Buti, Sebastiano
    Sacco, Cosimo
    Basso, Umberto
    Zustovich, Fable
    Lodde, Michele
    Perin, Alessandra
    Facchini, Gaetano
    Veccia, Antonello
    Maines, Francesca
    Barile, Carmen
    Fratino, Lucia
    Gernone, Angela
    De Vivo, Rocco
    Pappagallo, Giovanni L.
    Galligioni, Enzo
    [J]. FUTURE ONCOLOGY, 2015, 11 (12) : 1845 - 1845
  • [40] Lack of Correlation between Epidermal Growth Factor Receptor Status and Response to Panitumumab Monotherapy in Metastatic Colorectal Cancer (vol 16, pg 2205, 2010)
    Hecht, J. R.
    Mitchell, E.
    Neubauer, M. A.
    Burris, H. A., III
    Swanson, P.
    Lopez, T.
    Buchanan, G.
    Reiner, M.
    Gansert, J.
    Jordan, B.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (10) : 2917 - 2917
12345